CAR-NK cell therapy combined with checkpoint inhibition induces a NKT cell response in glioblastoma

被引：0

作者：

Strassheimer, Florian ^{[1
,2
,3
,4
]}

Elleringmann, Philipp ^{[1
,2
,3
,4
]}

Roller, Bastian ^{[1
,2
,3
,4
]}

Macas, Jadranka ^{[2
,5
]}

Alekseeva, Tijna ^{[2
,6
]}

Aliraj, Blerina ^{[2
,7
]}

Weber, Katharina ^{[2
,3
,4
,5
]}

Demes, Melanie ^{[8
]}

Tonn, Torsten ^{[9
]}

Reib, Yvonne ^{[2
,3
,4
,5
]}

Plate, Karl ^{[2
,3
,4
,5
]}

Weigert, Andreas ^{[2
,3
,4
,7
]}

Wels, Winfried ^{[2
,3
,4
,6
]}

Steinbach, Joachim ^{[1
,2
,3
,4
]}

Burger, Michael ^{[1
,2
,3
,4
]}

机构：

[1] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany

[2] Goethe Univ Frankfurt, Frankfurt Canc Inst FCI, Frankfurt, Germany

[3] German Canc Consortium DKTK, Heidelberg, Germany

[4] German Canc Res Ctr, Heidelberg, Germany

[5] Goethe Univ Frankfurt, Univ Hosp, Inst Neurol, Edinger Inst, Frankfurt, Germany

[6] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany

[7] Goethe Univ Frankfurt, Inst Biochem 1, Frankfurt, Germany

[8] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Pathol, Frankfurt, Germany

[9] Goethe Univ Frankfurt, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donat Serv Baden Wurttembe, Frankfurt, Germany

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

1921 - WS4

引用

页码：302 / 302

页数：1

共 50 条

[41] Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology-based strategies for enhanced CAR T/NK cell therapy
Dana, Nasim
Dabiri, Arezou
Najafi, Majed Bahri
Rahimi, Azadeh
Ishaghi, Sayed Mohammad Matin
Shariati, Laleh
Shao, Minmin
Borzacchiello, Assunta
Rahimmanesh, Ilnaz
Makvandi, Pooyan
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2025, 10 (02)
[42] DEVELOPMENT OF AN OFF-THE-SHELF BCMA/CD19 CAR-NK CELL THERAPY FOR B CELL MALIGNANCIES
Roex, G.
Campillo-Davo, D.
De Reu, H.
Berneman, Z.
Lion, E.
Anguille, S.
HUMAN GENE THERAPY, 2022, 33 (7-8) : A29 - A30
[43] Optimized chimeric antigen receptors (CARs) for CAR-NK cell therapies
Yang, Cuiqing
Wang, Yifang
Liu, Tingting
Jiang, Fuwei
Wang, Qingyang
Wang, Qin
Ye, Gang
Tang, Renhong
Cao, Zhouxiao
CANCER RESEARCH, 2023, 83 (07)
[44] CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Taheri, Mohadeseh Mohammad
Javan, Fatemeh
Poudineh, Mohadeseh
Athari, Seyyed Shamsadin
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2024, 66 (03) : 328 - 362
[45] Comparative evaluation of CAR-NK and CAR-T cell therapy for HNSCC: a novel approach with enhanced accessibility and safety
Hernandez-Gamarra, M.
Dominguez, E.
Veiga-Rua, S.
Salgado-Roo, A.
Pedrera-Garbayo, L. F.
Carracedo, A.
Allegue, C.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A218 - A218
[46] CAIX-specific CAR-NK targeting renal cell carcinoma
Oosterwijk-Wakka, J. C.
Xu, J. Y.
De Weijert, M. C. A.
Kenyon, A. N.
De Jonge, P. K. J. D.
Dolstra, H.
Mulders, P. F. A.
Oosterwijk, E.
EUROPEAN UROLOGY, 2022, 81 : S1638 - S1638
[47] Targeting KIR as a novel approach to improve CAR-NK cell function
Graham, Lara, V
Fisher, Jack G.
Khakoo, Salim I.
Blunt, Matthew D.
JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2023, 7 (04) : 230 - 235
[48] CAR-NK Cells for Cancer Therapy: Molecular Redesign of the Innate Antineoplastic Response
Cienfuegos-Jimenez, Oscar
Vazquez-Garza, Eduardo
Rojas-Martinez, Augusto
CURRENT GENE THERAPY, 2022, 22 (04) : 303 - 318
[49] AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma
Strecker, M., I
Wlotzka, K.
Strassheimer, F.
Roller, B.
Ludmirski, G.
Konig, S.
Roder, J.
Opitz, C.
Alekseeva, T.
Reul, J.
Sevenich, L.
Tonn, T.
Wels, W. S.
Steinbach, J. P.
Buchholz, C. J.
Burger, M. C.
ONCOIMMUNOLOGY, 2022, 11 (01):
[50] Dual-targeted CAR-NK cell therapy: optimized CAR design to prevent antigen escape and elicit a deep and durable response in multiple myeloma
Yang, Cuiqing
Wang, Yifang
Liu, Tingting
Wang, Chao
Wang, Huanyu
Wang, Qingyang
Wang, Qin
Ye, Gang
Tang, Renhong
Cao, Zhuoxiao
CANCER RESEARCH, 2023, 83 (07)

← 1 2 3 4 5 →